What Now: Relevance of Xylazine in the Age of Opioid Use Disorder - Guidance for OUD Treatment Providers On-Demand-Presentation

Video Transcription

Video Summary

In summary, the webinar titled "What Now? of Xylozine in the Age of Opioid Use Disorder" provided guidance for OUD treatment providers. Dr. Daniel Rosa, a senior medical director at Acacia Network, discussed the prevalence and relevance of Xylozine in OUD, medical issues associated with its use, and effective treatment options. Xylozine is often used as an adulterant in illicit drugs like fentanyl, contributing to overdose deaths. Treatment options include medication for opioid use disorder (MOUD) and naloxone for overdose rescue. Xylozine-related lesions can occur anywhere on the body and may require wound care. Outreach workers and those working with high-risk populations should provide wound care supplies, educate individuals, and encourage seeking medical attention. There were discussions on detoxing from Xylozine, use of alternatives to Clonidine, such as guanfacine, and the importance of collaboration with veterinarians. Further resources and support were highlighted for clinicians and individuals seeking information on evidence-based practices for OUD treatment.

Keywords

MOUD

recovery housing

holistic care

collaboration

12-step programs

smart recovery

medication-assisted treatments

open-mindedness

supportive environment

Xylozine

Opioid Use Disorder

OUD treatment

fentanyl

overdose deaths

naloxone

wound care

detoxing

evidence-based practices